HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Mamori Tani Selected Research
Mamori Tani Research Topics
Disease
2
Systemic Scleroderma (Systemic Sclerosis)
11/2022 - 03/2014
2
Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
07/2019 - 02/2017
2
Neoplasms (Cancer)
09/2014 - 08/2010
2
Annular Erythema
04/2014 - 09/2012
2
Pyoderma Gangrenosum
05/2011 - 12/2007
2
Ulcer
09/2008 - 12/2007
1
Localized Scleroderma (Morphea)
11/2022
1
Hypertriglyceridemia
02/2017
1
Bullous Pemphigoid (Pemphigoid)
02/2017
1
Neutropenia
02/2017
1
Leukopenia
02/2017
1
B-Cell Lymphoma (Lymphoma, B Cell)
09/2014
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2014
1
digital ulcers
03/2014
1
Atrophy
01/2014
1
Mycosis Fungoides
01/2014
1
Psoriatic Arthritis
11/2012
1
Rheumatoid Arthritis
11/2012
1
Hereditary Angioedemas
11/2012
1
Allergic Contact Dermatitis
09/2012
1
Neuroblastoma
09/2012
1
Hyperalgesia
09/2012
1
Arthritis (Polyarthritis)
06/2011
1
Staphylococcal Scalded Skin Syndrome (Ritter's Disease)
06/2011
1
Infectious Arthritis (Septic Arthritis)
06/2011
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2011
1
Neoplasm Metastasis (Metastasis)
01/2011
1
Skin Diseases (Skin Disease)
12/2010
1
Hypersensitivity (Allergy)
12/2010
1
Carcinoma (Carcinomatosis)
08/2010
1
Fever (Fevers)
03/2010
1
Lymphadenopathy
03/2010
1
Inflammation (Inflammations)
09/2008
1
Collagen Diseases (Collagen Disease)
09/2008
1
Blister (Bulla)
06/2008
1
Chronic Kidney Failure (Chronic Renal Failure)
12/2007
1
Calciphylaxis
12/2007
1
Leg Ulcer
12/2007
1
Wounds and Injuries (Trauma)
12/2007
1
Arteriosclerosis Obliterans
12/2007
Drug/Important Bio-Agent (IBA)
2
Bexarotene (LGD1069)
FDA Link
07/2019 - 02/2017
2
Steroids
IBA
02/2017 - 05/2011
1
RNA Polymerase III
IBA
11/2022
1
Intravenous Immunoglobulins (IVIG)
FDA Link
02/2017
1
Alanine Transaminase (SGPT)
IBA
02/2017
1
Retinoid X Receptors (Retinoid X Receptor)
IBA
02/2017
1
Retinoids
IBA
02/2017
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
02/2017
1
Rituximab (Mabthera)
FDA Link
09/2014
1
Interleukin-17 (Interleukin 17)
IBA
04/2014
1
Ficusin (Psoralen)
IBA
03/2014
1
Collagen
IBA
01/2014
1
Interferon-gamma (Interferon, gamma)
IBA
01/2014
1
Interferons
IBA
01/2014
1
Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)
IBA
11/2012
1
Etanercept (Enbrel)
FDA Link
11/2012
1
Substance P
IBA
09/2012
1
Palladium
IBA
09/2012
1
Hyaluronic Acid (Hyaluronan)
IBA
06/2011
1
Hypnotics and Sedatives (Sedatives)
IBA
12/2010
1
Histamine Antagonists (Antihistamines)
IBA
12/2010
1
beta Catenin
IBA
08/2010
1
Alprostadil (Muse)
FDA Link
Generic
09/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
09/2008
1
C-Reactive Protein
IBA
09/2008
1
Interleukin-6 (Interleukin 6)
IBA
09/2008
1
Cytokines
IBA
09/2008
1
Etidronic Acid (HEDP)
FDA Link
Generic
12/2007
1
Diphosphonates (Bisphosphonates)
IBA
12/2007
Therapy/Procedure
2
Therapeutics
03/2014 - 12/2010
1
Inlays (Inlay)
09/2012
1
Intradermal Injections
09/2012
1
Injections
06/2011
1
Intra-Articular Injections
06/2011
1
Surgical Amputation (Amputations)
01/2011
1
Neoadjuvant Therapy
01/2011
1
Combination Drug Therapy (Combination Chemotherapy)
03/2010
1
Local Anesthesia
06/2008
1
Debridement
12/2007
1
Renal Dialysis (Hemodialysis)
12/2007